ID
28156
Description
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Investigational product Repeating form (Scheduled visits)
Keywords
Versions (5)
- 9/24/17 9/24/17 -
- 9/24/17 9/24/17 -
- 10/4/17 10/4/17 -
- 10/23/17 10/23/17 -
- 12/22/17 12/22/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
December 22, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Investigational product Repeating form GSK study Chronic Coronary Heart Disease NCT00799903
Investigational product Repeating form GSK study Chronic Coronary Heart Disease NCT00799903
Description
Investigational product compliance
Description
Visit
Data type
integer
Alias
- UMLS CUI [1]
- C0545082
Description
Bottle Code
Data type
integer
Alias
- UMLS CUI [1]
- C0179376
Description
Total Number Dispensed
Data type
integer
Alias
- UMLS CUI [1]
- C0805077
Description
Total Number Returned
Data type
integer
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0039225
Description
Total Number Taken
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C1883727
Similar models
Investigational product Repeating form GSK study Chronic Coronary Heart Disease NCT00799903
C0039225 (UMLS CUI [1,2])
C1883727 (UMLS CUI [1,2])